Ambrx Biopharma Inc. Lessee, Operating Lease, Liability, to be Paid
Ambrx Biopharma Inc. had Lessee, Operating Lease, Liability, to be Paid of $14.65 million as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-03-30
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $14.65M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $16.53M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2022-12-31 | $14.65M 10-K · filed 2023-03-30 |
| 2021-12-31 | $16.53M 20-F · filed 2022-04-26 |